0
0
38 words
0
Comments
A study followed a neonatal cohort with sickle cell disease for up to 20 years. The study demonstrated how hydroxyurea lowers the risk of high mortality.
You are the first to view
https://www.hcplive.com/view/hydroxyurea-treatment-associated-improving-sickle-cell-disease-in-children
Create an account or login to join the discussion